BioCentury
ARTICLE | Clinical News

AG014: Phase I data

November 10, 2014 8:00 AM UTC

An open-label, Belgian Phase I trial in healthy volunteers showed that oral AG014 was well tolerated. Pharmacokinetic data showed that AG014 bacteria were released at the targeted gastrointestinal reg...